Follow the latest news and projects about COVID-19 and the European Commission's coronavirus response.

Skip to main content
EnglishEN

Predicting clinical response to anticancer drugs using 3D-bioprinted tumor models for personalized therapy

Project description

DEENESFRITPL

Recreating a patient's tumour ecoystem with 3D printing will foster precision treatment

Fields of science

Programme(s)

Topic(s)

Call for proposal

ERC-2019-PoC

See other projects for this call

Funding Scheme

ERC-POC-LS - ERC Proof of Concept Lump Sum Pilot

Host institution

TEL AVIV UNIVERSITY
Net EU contribution
€ 150 000,00
Address
Ramat Aviv
69978 Tel Aviv
Israel
Contact the organisation Opens in new window
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
No data
 
Website Opens in new window
Participation in EU R&I programmes Opens in new window

Beneficiaries (1)

TEL AVIV UNIVERSITY
Israel
Net EU contribution
€ 150 000,00
Address
Ramat Aviv
69978 Tel Aviv
Contact the organisation Opens in new window
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
No data
 
Website Opens in new window
Participation in EU R&I programmes Opens in new window

Share this page

Download

EC signature date: 26 August 2019
Last update: 28 April 2022
Record number: 224839

My Booklet

Permalink: https://cordis.europa.eu/project/id/862580

© European Union, 2022